Haymaker Acquisition Corp. III

Status: Deal Closed
U=S+W/4 W=S@11.5
IPO Proceeds, $M $317.50M
IPO Date Mar 2, 2021
CEO Steven J. Heyer
Left Lead Citigroup
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Consumer
IPO Geography US/Canada
Target Company BioTE Holdings
Deal Announced Dec 13, 2021
Deal Size, $M $667.00M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote May 24, 2022
Amendment Vote TBD
Closing Date May 26, 2022
Formerly HYAC BTMD BTMDW

Sign up for Free Trial

No credit card required

Sign in for more on Haymaker Acquisition Corp. III:

  • Structure and cap table
  • 7 directors & officers
  • 23 filings and events
  • 2 underwriters
  • 9 deal advisors
  • 3 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Steven J. Heyer 68 Chief Executive Officer and Director
Andrew R. Heyer 63 President and Director
Christopher Bradley 43 Chief Financial Officer and Secretary
Joseph M. Tonnos 33 Senior Vice President
Roger Meltzer 69 Director
Frederic H. Mayerson 74 Director
Stephen W. Powell 62 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Citigroup Joint BR 18,000,000 units
Cantor Fitzgerald Joint BR 12,000,000
30,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 23 filings.

Shareholders

Sign in to view shareholders 13F filing data.